Structure Therapeutics (GPCR) Operating Leases (2023 - 2026)

Structure Therapeutics' Operating Leases history runs 4 years deep, the most recent figure standing at $3.2 million for Q1 2026.

• In Q1 2026, Operating Leases fell 37.78% year-over-year to $3.2 million; the TTM figure through Mar 2026 stood at $3.2 million (down 37.78% YoY), while the FY2025 annual figure was $3.6 million, up 66.77% from the prior year.
• Operating Leases was $3.2 million for Q1 2026 at Structure Therapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Operating Leases ranged from a high of $5.1 million in Q1 2025 to a low of $2.2 million in Q4 2024.
• Historically, Operating Leases has averaged $3.6 million across 4 years, with a median of $3.5 million in 2024.
• The sharpest annual moves came in 2024 and 2025: Operating Leases tumbled 46.08% in 2024, then soared 66.77% in 2025.
• A 4-year view of Operating Leases shows it stood at $4.0 million in 2023, then sank by 46.08% to $2.2 million in 2024, then jumped by 66.77% to $3.6 million in 2025, then fell by 11.8% to $3.2 million in 2026.
• The last three Operating Leases figures came in at $3.2 million (Q1 2026), $3.6 million (Q4 2025), and $4.3 million (Q3 2025), per Business Quant data.